BR9916888A - Uso de compostos e seus sais com ácidosfarmacologicamente aceitáveis - Google Patents
Uso de compostos e seus sais com ácidosfarmacologicamente aceitáveisInfo
- Publication number
- BR9916888A BR9916888A BR9916888-0A BR9916888A BR9916888A BR 9916888 A BR9916888 A BR 9916888A BR 9916888 A BR9916888 A BR 9916888A BR 9916888 A BR9916888 A BR 9916888A
- Authority
- BR
- Brazil
- Prior art keywords
- salts
- compounds
- pharmacologically acceptable
- acceptable acids
- acids
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 3
- 150000007513 acids Chemical class 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19900544A DE19900544A1 (de) | 1999-01-11 | 1999-01-11 | Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie |
| PCT/EP1999/010275 WO2000041697A1 (de) | 1999-01-11 | 1999-12-22 | Verwendung von 2-substituierten 1,2-benzisothiazol-derivaten und von 3-substituierten tetrahydropyridopyrimidinon-derivaten zur prophylaxe und therapie der zerebralen ischämie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916888A true BR9916888A (pt) | 2001-11-20 |
Family
ID=7893835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916888-0A BR9916888A (pt) | 1999-01-11 | 1999-12-22 | Uso de compostos e seus sais com ácidosfarmacologicamente aceitáveis |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1140099A1 (hu) |
| JP (1) | JP2002534467A (hu) |
| KR (1) | KR20010101440A (hu) |
| CN (1) | CN1333685A (hu) |
| AR (1) | AR029741A1 (hu) |
| AU (1) | AU2285100A (hu) |
| BG (1) | BG105688A (hu) |
| BR (1) | BR9916888A (hu) |
| CA (1) | CA2359390A1 (hu) |
| DE (1) | DE19900544A1 (hu) |
| HU (1) | HUP0200520A3 (hu) |
| IL (1) | IL144145A0 (hu) |
| MX (1) | MXPA01006966A (hu) |
| NO (1) | NO20013408L (hu) |
| PL (1) | PL348916A1 (hu) |
| SK (1) | SK9682001A3 (hu) |
| TR (1) | TR200102009T2 (hu) |
| WO (1) | WO2000041697A1 (hu) |
| ZA (1) | ZA200105473B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1560488B1 (en) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Antibacterial agents |
| JP4794446B2 (ja) * | 2003-09-23 | 2011-10-19 | メルク・シャープ・エンド・ドーム・コーポレイション | イソキノリン系カリウムチャンネル阻害薬 |
| US8097610B2 (en) * | 2005-08-26 | 2012-01-17 | Shionogi & Co., Ltd. | Derivative having PPAR agonistic activity |
| WO2009038752A2 (en) * | 2007-09-20 | 2009-03-26 | Cortex Pharmaceuticals, Inc. | 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses |
| MA41168A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
| CN108484594B (zh) * | 2018-02-09 | 2020-08-04 | 福建医科大学 | 一种烷氧基取代四氢吡啶并嘧啶类化合物或其可用盐及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3620643A1 (de) * | 1985-06-22 | 1987-01-22 | Sandoz Ag | Thiazole, ihre herstellung und verwendung |
| DE3831888A1 (de) * | 1988-09-20 | 1990-03-29 | Troponwerke Gmbh & Co Kg | Arzneimittel zur behandlung von apoplexia cerebri |
| JP3036789B2 (ja) * | 1990-06-22 | 2000-04-24 | 三井化学株式会社 | 新規な複素環式化合物及び医薬組成物 |
| DE19746612A1 (de) * | 1997-10-22 | 1999-04-29 | Basf Ag | 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung |
| DE19747063A1 (de) * | 1997-10-24 | 1999-04-29 | Basf Ag | 3-substituierte Tetrahydropyridopyrimidinon-Derivate, ihre Herstellung und Verwendung |
-
1999
- 1999-01-11 DE DE19900544A patent/DE19900544A1/de not_active Withdrawn
- 1999-12-22 BR BR9916888-0A patent/BR9916888A/pt not_active IP Right Cessation
- 1999-12-22 TR TR2001/02009T patent/TR200102009T2/xx unknown
- 1999-12-22 EP EP99966990A patent/EP1140099A1/de not_active Withdrawn
- 1999-12-22 KR KR1020017008690A patent/KR20010101440A/ko not_active Application Discontinuation
- 1999-12-22 CN CN99815452A patent/CN1333685A/zh active Pending
- 1999-12-22 CA CA002359390A patent/CA2359390A1/en not_active Abandoned
- 1999-12-22 SK SK968-2001A patent/SK9682001A3/sk unknown
- 1999-12-22 AU AU22851/00A patent/AU2285100A/en not_active Abandoned
- 1999-12-22 WO PCT/EP1999/010275 patent/WO2000041697A1/de not_active Application Discontinuation
- 1999-12-22 HU HU0200520A patent/HUP0200520A3/hu unknown
- 1999-12-22 IL IL14414599A patent/IL144145A0/xx unknown
- 1999-12-22 JP JP2000593308A patent/JP2002534467A/ja active Pending
- 1999-12-22 MX MXPA01006966A patent/MXPA01006966A/es unknown
- 1999-12-22 PL PL99348916A patent/PL348916A1/xx not_active Application Discontinuation
-
2000
- 2000-01-06 AR ARP000100036A patent/AR029741A1/es unknown
-
2001
- 2001-07-03 ZA ZA200105473A patent/ZA200105473B/xx unknown
- 2001-07-10 NO NO20013408A patent/NO20013408L/no not_active Application Discontinuation
- 2001-07-10 BG BG105688A patent/BG105688A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2359390A1 (en) | 2000-07-20 |
| HUP0200520A3 (en) | 2003-04-28 |
| SK9682001A3 (en) | 2002-03-05 |
| JP2002534467A (ja) | 2002-10-15 |
| KR20010101440A (ko) | 2001-11-14 |
| BG105688A (en) | 2002-02-28 |
| MXPA01006966A (es) | 2002-04-10 |
| AR029741A1 (es) | 2003-07-16 |
| WO2000041697A1 (de) | 2000-07-20 |
| CN1333685A (zh) | 2002-01-30 |
| HUP0200520A2 (hu) | 2002-07-29 |
| ZA200105473B (en) | 2002-10-03 |
| IL144145A0 (en) | 2002-05-23 |
| NO20013408D0 (no) | 2001-07-10 |
| PL348916A1 (en) | 2002-06-17 |
| EP1140099A1 (de) | 2001-10-10 |
| DE19900544A1 (de) | 2000-07-13 |
| TR200102009T2 (tr) | 2002-01-21 |
| NO20013408L (no) | 2001-08-21 |
| AU2285100A (en) | 2000-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
| BR0017030A (pt) | Derivados de tiazolilamida | |
| SV2002000356A (es) | Nuevos derivados de piperazina ref. pc10770aixn/bb | |
| BR0207726A (pt) | Sais farmacêuticos | |
| SV1999000048A (es) | Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv | |
| BR0112986A (pt) | Compostos azabicìclicos, o respectivo preparo e a respectiva utilização como medicamentos, notadamente como antibacteriano | |
| BR0111667A (pt) | Novos compostos | |
| BR0211805A (pt) | Herbicidas | |
| BR0308212A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BR0306957A (pt) | Herbicidas | |
| BR0315665A (pt) | Antagonistas de cgrp selecionados, processos para preparação dos mesmos, bem como uso dos mesmos como medicamento | |
| BRPI0412291A (pt) | antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia | |
| BR0114159A (pt) | Herbicidas de fenilpropiniloxipiridina | |
| BR0210531A (pt) | Derivados de ácido sulfÈnico | |
| BR0307461A (pt) | Derivados de quinazolinona e seu uso como agonistas de cb | |
| BR0012951A (pt) | Agonistas de retinóides seletivos | |
| BR0011831A (pt) | Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos | |
| ES2172937T3 (es) | 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides. | |
| BR0314195A (pt) | Derivados de piridina substituìda como agentes antitumorais | |
| BR0207166A (pt) | Composto, e, composição farmacêutica | |
| GEP20043162B (en) | Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance | |
| TR200400228T4 (tr) | Psöryazinin tedavisinde kullanılacak maddeler | |
| BR0315320A (pt) | Composto ou sais farmaceuticamente aceitáveis dos mesmos, uso de um composto, composição farmacêutica, e, métodos para a terapia de dor em um animal de sangue quente e para produzir um composto | |
| AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
| BR9916888A (pt) | Uso de compostos e seus sais com ácidosfarmacologicamente aceitáveis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4O, 5O, 6O E 7O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |